BackEuropean Biotech Acquisition Overview

European Biotech Acquisition Profit Margin

Latest profit margin for European Biotech Acquisition: Infinity% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Dec 2022

Annual Profit Margin (TTM)

N/A

Trailing 12 months ending Dec 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

European Biotech Acquisition (EBAC) FAQ

As of the most recent data (December 2022), EBAC shows a profit margin of Infinity%. That is above the sector sector average of 19.69%. Scroll down for historical charts and peer comparison views.

The its sector sector average profit margin is about 19.69%. European Biotech Acquisition is at Infinity%, which is higher that average. That is roughly Infinity% above the sector mean. Use the comparison chart on this page to see how EBAC stacks up against individual peers as well.

Check the historical chart to see whether EBAC's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare European Biotech Acquisition with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has European Biotech Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently Infinity%) with ownership activity and broader fundamentals.